NASDAQ · ACHV
Achieve Life Sciences, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for ACHV: Nov 5, 2026
Achieve Life Sciences, Inc. Common Shares is estimated to report earnings on 11/05/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 5 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.2. The reported EPS for the same quarter last year was $-0.28.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.20 | $-0.16 | $-0.22 | 5 |
| Dec 2026 | $-0.22 | $-0.15 | $-0.26 | 5 |
| Mar 2027 | $-0.17 | $-0.03 | $-0.27 | 3 |
| Jun 2027 | $-0.14 | $-0.06 | $-0.21 | 3 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · Fintel · MarketBeat · The Motley Fool- RTTNews · Oct 23, 10:53 AM EDTWeekly Buzz: AZN, ALVO Score FDA Nod; EYPT Cuts Jobs; RHHBY, GEHC Enter Deal; VERA Posts Trial Win(RTTNews) – Healthcare and biotech news this week centred on regulatory approvals, strategic deals, and pivotal clinical data.
- RTTNews · Oct 21, 12:56 PM EDTAchieve's Cytisinicline Shows 31% Smoking And Vaping Cessation Rate At One Year; Stock Up(RTTNews) – Achieve Life Sciences (ACHV) presented new 52-week results from its ORCA-OL clinical trial showing that extended treatment with cytisinicline helped a meaningful proportion of participants quit smoking or vaping, including individuals who had previously failed a medic
- RTTNews · Oct 1, 8:51 AM EDTAchieve Life Sciences Appoints Benjamin Halladay As CFO(RTTNews) – Achieve Life Sciences, Inc. (ACHV), a late-stage specialty pharmaceutical company, said on Thursday that it has appointed Benjamin Halladay as chief financial officer with effect from October 5. He will succeed Mark Oki, who will step down as CFO on the same day.
- Fintel · Sep 30, 11:29 AM EDTStifel Initiates Coverage of Achieve Life Sciences with BuyFintel reports that on September 30, 2026, Stifel initiated coverage of Achieve Life Sciences (NASDAQCM:ACHV) (DB:SP4P) with a Buy recommendation.Achieve Life Sciences, Inc., based in the United States, operates within the biopharmaceutical industry focused on developing and comm
- RTTNews · Aug 11, 12:22 PM EDTAchieve Life Sciences Strengthens Cytisinicline Path To FDA Approval; Targets Decision In H1 FY27(RTTNews) – Achieve Life Sciences, Inc. (ACHV), a late-stage specialty pharmaceutical company focused on developing and commercializing Cytisinicline for Nicotine dependence, recently reported its second-quarter 2026 financial results and provided business updates. Investors are
- MarketBeat · Jul 9, 8:01 PM EDTAchieve Life Sciences Stockholders Weigh Board Slate, Share Increase at Annual MeetingAchieve Life Sciences (NASDAQ:ACHV) held its 2026 Annual Meeting of Stockholders virtually, with Chief Executive Officer Andrew Goldberg serving as chairperson of the meeting. Goldberg called the meeting to order and said Erik Atkisson, the company’s Chief Legal Officer, would ac
- RTTNews · Jun 26, 10:33 AM EDTWeekly Buzz: IONS, MRK Get FDA Approvals; ACHV Gets CRL; ADCT Cuts Jobs; TECH Acquired(RTTNews) – This week, the biotech sector delivered a mix of FDA and EU approvals, strategic reorganizations, layoff, acquisitions, and late-stage clinical readouts across oncology, metabolic disease, neurology and immunology.
- RTTNews · Jun 22, 11:40 AM EDTFDA Issues CRL To Achieve Life Sciences For Cytisinicline NDA Over CGMP Manufacturing Concerns(RTTNews) – Achieve Life Sciences, Inc. (ACHV), a late-stage pharmaceutical company, announced that the U.S. Food and Drug Administration has issued a Complete Response Letter (CRL) for the New Drug Application (NDA) of Cytisinicline as a treatment for nicotine dependence.
- RTTNews · May 20, 2:56 AM EDTAchieve Life Sciences Unveils 52 Week Safety Data Of Cytisinicline Ahead Of FDA Decision(RTTNews) – Achieve Life Sciences, Inc. (ACHV), a late-stage specialty pharmaceutical company, announced the presentation of long-term safety data from the ORCA-OL study evaluating its lead investigational candidate, Cytisinicline, for treating nicotine dependence at the American
- The Motley Fool · May 12, 12:56 PM EDTAchieve (ACHV) Q1 2026 Earnings Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- MarketBeat · May 12, 10:08 AM EDTAchieve Life Sciences Q1 Earnings Call HighlightsAchieve Life Sciences (NASDAQ:ACHV) used its first-quarter 2026 earnings call to outline a transition period marked by new leadership, a major financing, manufacturing changes tied to its cytisinicline regulatory timeline and preparations for a potential commercial launch in 2027
- Fintel · Apr 21, 8:04 PM EDTCanaccord Genuity Initiates Coverage of Achieve Life Sciences (ACHV) with Buy RecommendationFintel reports that on April 21, 2026, Canaccord Genuity initiated coverage of Achieve Life Sciences (NasdaqCM:ACHV) with a Buy recommendation. Analyst Price Forecast Suggests 278.61% Upside
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Achieve Life Sciences, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.